Sanofi’s efdoralprin alfa receives EU orphan designation for rare lung disease December 17, 2025 by wealthalpha Other news Sanofi’s efdoralprin alfa receives EU orphan designation for rare lung disease Source link Previous News Apple in talks with Indian chipmakers over iPhone components- ET Next News Rising mutual fund firepower softens impact of FII outflows, say market veterans wealthalpha
Leave A Comment